Business News • PR NewsWire • CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2

CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2

CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2

LUXEMBOURG, May 28, 2020 /PRNewswire/ -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna,...

View More : https://www.prnewswire.com:443/news-releases/cordenpharma--moderna-extend-strategic-manufacturing-services-agreement-for...

Releted News by prnewswire

Yintech Reports First Quarter 2020 Unaudited Financial Results

New FlowForma Software Release Helps Construction Sector With 'Paper To Data' Transformation

Ping An's Object Detection Model Breaks Record in International Computer Vision Competition

IntegriCulture Inc. Closes Series A Fundraising Round Led by Beyond Next Ventures at JPY800 Million

Fire in Crushing Station at Boliden Kevitsa